Literature DB >> 30243621

Earlier Colorectal Cancer Screening May Be Necessary In Patients With Li-Fraumeni Syndrome.

Suzanne P MacFarland1, Kristin Zelley1, Jessica M Long2, Danielle McKenna2, Petar Mamula3, Susan M Domchek2, Katherine L Nathanson4, Garrett M Brodeur1, Anil K Rustgi5, Bryson W Katona6, Kara N Maxwell3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30243621      PMCID： PMC6309491          DOI： 10.1053/j.gastro.2018.09.036

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  8 in total

1.  Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.

Authors:  Phuong L Mai; Ana F Best; June A Peters; Rosamma M DeCastro; Payal P Khincha; Jennifer T Loud; Renée C Bremer; Philip S Rosenberg; Sharon A Savage
Journal:  Cancer       Date:  2016-08-06       Impact factor: 6.860

2.  Colon Pathology Characteristics in Li-Fraumeni Syndrome.

Authors:  William Rengifo-Cam; Hailey M Shepherd; Kory W Jasperson; N Jewel Samadder; Wade Samowitz; Sheryl R Tripp; Joshua D Schiffman; Wendy Kohlmann
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-15       Impact factor: 11.382

3.  TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data.

Authors:  Liacine Bouaoun; Dmitriy Sonkin; Maude Ardin; Monica Hollstein; Graham Byrnes; Jiri Zavadil; Magali Olivier
Journal:  Hum Mutat       Date:  2016-07-08       Impact factor: 4.878

4.  Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.

Authors:  Patricia Wong; Sigitas J Verselis; Judy E Garber; Katherine Schneider; Lisa DiGianni; David H Stockwell; Frederick P Li; Sapna Syngal
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

5.  Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia.

Authors:  Jaroslaw Regula; Maciej Rupinski; Ewa Kraszewska; Marcin Polkowski; Jacek Pachlewski; Janina Orlowska; Marek P Nowacki; Eugeniusz Butruk
Journal:  N Engl J Med       Date:  2006-11-02       Impact factor: 91.245

6.  Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.

Authors:  Anita Villani; Ari Shore; Jonathan D Wasserman; Derek Stephens; Raymond H Kim; Harriet Druker; Bailey Gallinger; Anne Naumer; Wendy Kohlmann; Ana Novokmet; Uri Tabori; Marta Tijerin; Mary-Louise C Greer; Jonathan L Finlay; Joshua D Schiffman; David Malkin
Journal:  Lancet Oncol       Date:  2016-08-05       Impact factor: 41.316

7.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

Review 8.  Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.

Authors:  Christian P Kratz; Maria Isabel Achatz; Laurence Brugières; Thierry Frebourg; Judy E Garber; Mary-Louise C Greer; Jordan R Hansford; Katherine A Janeway; Wendy K Kohlmann; Rose McGee; Charles G Mullighan; Kenan Onel; Kristian W Pajtler; Stefan M Pfister; Sharon A Savage; Joshua D Schiffman; Katherine A Schneider; Louise C Strong; D Gareth R Evans; Jonathan D Wasserman; Anita Villani; David Malkin
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531
  8 in total
  8 in total

1.  Inherited TP53 Variants and Risk of Prostate Cancer.

Authors:  Kara N Maxwell; Heather H Cheng; Jacquelyn Powers; Roman Gulati; Elisa M Ledet; Casey Morrison; Anh Le; Ryan Hausler; Jill Stopfer; Sophie Hyman; Wendy Kohlmann; Anne Naumer; Jennie Vagher; Samantha E Greenberg; Lorraine Naylor; Mercy Laurino; Eric Q Konnick; Brian H Shirts; Saud H AlDubayan; Eliezer M Van Allen; Bastien Nguyen; Joseph Vijai; Wassim Abida; Maria I Carlo; Marianne Dubard-Gault; Daniel J Lee; Luke D Maese; Diana Mandelker; Bruce Montgomery; Michael J Morris; Piper Nicolosi; Robert L Nussbaum; Lauren E Schwartz; Zsofia Stadler; Judy E Garber; Kenneth Offit; Joshua D Schiffman; Peter S Nelson; Oliver Sartor; Michael F Walsh; Colin C Pritchard
Journal:  Eur Urol       Date:  2021-12-01       Impact factor: 20.096

2.  Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.

Authors:  Anh N Le; Joanna Harton; Heena Desai; Jacquelyn Powers; Kristin Zelley; Angela R Bradbury; Katherine L Nathanson; Payal D Shah; Abigail Doucette; Gary M Freedman; Peter Gabriel; Susan M Domchek; Suzanne P MacFarland; Kara N Maxwell
Journal:  Breast Cancer Res Treat       Date:  2020-04-03       Impact factor: 4.872

3.  A Rare TP53 Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple Cancers.

Authors:  Jacquelyn Powers; Emilia M Pinto; Thibaut Barnoud; Jessica C Leung; Tetyana Martynyuk; Andrew V Kossenkov; Aaron H Philips; Heena Desai; Ryan Hausler; Gregory Kelly; Anh N Le; Marilyn M Li; Suzanne P MacFarland; Louise C Pyle; Kristin Zelley; Katherine L Nathanson; Susan M Domchek; Thomas P Slavin; Jeffrey N Weitzel; Jill E Stopfer; Judy E Garber; Vijai Joseph; Kenneth Offit; Jill S Dolinsky; Stephanie Gutierrez; Kelly McGoldrick; Fergus J Couch; Brooke Levin; Morris C Edelman; Carolyn Fein Levy; Sheri L Spunt; Richard W Kriwacki; Gerard P Zambetti; Raul C Ribeiro; Maureen E Murphy; Kara N Maxwell
Journal:  Cancer Res       Date:  2020-07-16       Impact factor: 12.701

Review 4.  Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis.

Authors:  Brandie Heald; Heather Hampel; James Church; Beth Dudley; Michael J Hall; Maureen E Mork; Aparajita Singh; Elena Stoffel; Jessica Stoll; Y Nancy You; Matthew B Yurgelun; Sonia S Kupfer
Journal:  Fam Cancer       Date:  2020-07       Impact factor: 2.375

5.  Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome.

Authors:  Bryson W Katona; Jacquelyn Powers; Danielle B McKenna; Jessica M Long; Anh N Le; Ryan Hausler; Kristin Zelley; Sarah Jennings; Susan M Domchek; Katherine L Nathanson; Suzanne P MacFarland; Kara N Maxwell
Journal:  Am J Gastroenterol       Date:  2020-12       Impact factor: 10.864

6.  Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni Syndrome.

Authors:  Farzana L Walcott; Ping-Yuan Wang; Christine M Bryla; Rebecca D Huffstutler; Neha Singh; Michael N Pollak; Payal P Khincha; Sharon A Savage; Phuong L Mai; Kevin W Dodd; Paul M Hwang; Antonio T Fojo; Christina M Annunziata
Journal:  JNCI Cancer Spectr       Date:  2020-07-18

7.  Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53.

Authors:  Emma Tham; Svetlana Bajalica-Lagercrantz; Meis Omran; Lennart Blomqvist; Yvonne Brandberg; Niklas Pal; Per Kogner; Anne Kinhult Ståhlbom
Journal:  Hered Cancer Clin Pract       Date:  2020-01-13       Impact factor: 2.857

Review 8.  Early Onset Colorectal Cancer: An Emerging Cancer Risk in Patients with Diamond Blackfan Anemia.

Authors:  Jeffrey M Lipton; Christine L S Molmenti; Pooja Desai; Alexander Lipton; Steven R Ellis; Adrianna Vlachos
Journal:  Genes (Basel)       Date:  2021-12-26       Impact factor: 4.096
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.